NDC 10019-553

Transderm Scop

Scopalamine

Transderm Scop is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Scopolamine.

• Product ID: 10019-553_37bb1b24-2674-45af-ac68-46d00cb41824
• NDC: 10019-553
• Product Type: Human Prescription Drug
• Proprietary Name: Transderm Scop
• Generic Name: Scopalamine
• Dosage Form: Patch, Extended Release
• Route of Administration: TRANSDERMAL
• Marketing Start Date: 2016-12-01
• Marketing Category: NDA / NDA
• Application Number: NDA017874
• Labeler Name: Baxter Healthcare Corporation
• Substance Name: SCOPOLAMINE
• Active Ingredient Strength: 1 mg/3d
• Pharm Classes: Anticholinergic [EPC],Cholinergic Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 10019-553-03

10 POUCH in 1 BOX (10019-553-03) > 1 PATCH in 1 POUCH > 3 d in 1 PATCH

• Marketing Start Date: 2016-12-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 10019-553-02 [10019055302]

Transderm Scop PATCH, EXTENDED RELEASE

• Marketing Category: NDA
• Application Number: NDA017874
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2003-01-01
• Marketing End Date: 2019-05-31

NDC 10019-553-03 [10019055303]

Transderm Scop PATCH, EXTENDED RELEASE

• Marketing Category: NDA
• Application Number: NDA017874
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2016-12-01

NDC 10019-553-88 [10019055388]

Transderm Scop PATCH, EXTENDED RELEASE

• Marketing Category: NDA
• Application Number: NDA017874
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2003-01-01
• Marketing End Date: 2019-05-31

NDC 10019-553-01 [10019055301]

Transderm Scop PATCH, EXTENDED RELEASE

• Marketing Category: NDA
• Application Number: NDA017874
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2003-01-01
• Marketing End Date: 2019-05-31

NDC 10019-553-90 [10019055390]

Transderm Scop PATCH, EXTENDED RELEASE

• Marketing Category: NDA
• Application Number: NDA017874
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2016-12-01

NDC 10019-553-04 [10019055304]

Transderm Scop PATCH, EXTENDED RELEASE

• Marketing Category: NDA
• Application Number: NDA017874
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2016-12-01

Drug Details

Active Ingredients

Ingredient	Strength
SCOPOLAMINE	1 mg/3d

OpenFDA Data

• SPL SET ID: b877a694-a1d0-4280-937a-a06820b12a88
• Manufacturer:
  • Baxter Healthcare Corporation
• UNII:
  • DL48G20X8X
• RxNorm Concept Unique ID - RxCUI:
  • 226552
  • 351875

Pharmacological Class

• Anticholinergic [EPC]
• Cholinergic Antagonists [MoA]
• Anticholinergic [EPC]
• Cholinergic Antagonists [MoA]

Medicade Reported Pricing

10019055390 TRANSDERM-SCOP 1.5 MG (1 MG/3D)

Pricing Unit: EA | Drug Type:

10019055388 TRANSDERM-SCOP 1.5 MG (1 MG/3D)

Pricing Unit: EA | Drug Type:

10019055304 TRANSDERM-SCOP 1.5 MG (1 MG/3D)

Pricing Unit: EA | Drug Type:

10019055303 TRANSDERM-SCOP 1.5 MG (1 MG/3D)

Pricing Unit: EA | Drug Type:

10019055302 TRANSDERM-SCOP 1.5 MG (1 MG/3D)

Pricing Unit: EA | Drug Type:

10019055301 TRANSDERM-SCOP 1.5 MG (1 MG/3D)

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Transderm Scop" or generic name "Scopalamine"

NDC	Brand Name	Generic Name
0067-4345	Transderm Scop	scopolamine
0067-4346	Transderm Scop	scopolamine
10019-553	Transderm Scop	Scopalamine
66758-208	Transderm Scop	scopolamine